Annexin A5 Protects SH-SY5Y Cells against L-Glutamate-Induced Cytotoxicity

Zahra Abedini1, Marzieh Mehdieh1, Mohammad Ali Takhshid1

  • 1Department of Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

PubMed
Abstract

Insights

Annexin A5 (ANXA5) protects against L-glutamate-induced neurotoxicity by preserving cell viability and mitochondrial function in SH-SY5Y cells. This suggests ANXA5 may be a potential therapeutic agent for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • L-glutamate neurotoxicity contributes to neuronal loss in conditions like stroke and neurodegenerative diseases.
  • Annexin A5 (ANXA5) is a calcium-binding protein with potential cytoprotective roles.
  • SH-SY5Y cells are a widely used human neuroblastoma cell line for studying neuronal processes.

Purpose of the Study:

  • To investigate the protective effects of recombinant Annexin A5 (ANXA5) against L-glutamate-induced neurotoxicity.
  • To assess ANXA5's impact on cell death and mitochondrial dysfunction in a cellular model.

Main Methods:

  • Recombinant ANXA5 was expressed and purified.
  • SH-SY5Y cell viability was measured using the MTT assay after L-glutamate exposure, with and without ANXA5.
  • Mitochondrial membrane potential (MMP) dissipation was analyzed via flow cytometry.
  • Gene expression of Bax, Bcl-2, and Nrf-2 was quantified using real-time PCR.

Main Results:

  • L-glutamate significantly reduced SH-SY5Y cell viability in a dose-dependent manner (IC50 = 165 mM).
  • L-glutamate exposure led to increased MMP dissipation, elevated Bax expression, and decreased Bcl-2 and Nrf-2 expression.
  • ANXA5 treatment reversed the detrimental effects of L-glutamate on cell viability, MMP, and gene expression.

Conclusions:

  • Annexin A5 demonstrates significant protective effects against L-glutamate-induced cell death and mitochondrial dysfunction in SH-SY5Y cells.
  • These findings suggest ANXA5 holds potential as a therapeutic agent to mitigate glutamate-induced neurodegeneration.

Related Concept Videos